Item 2. Properties
Item
2. Properties.
Our
corporate headquarters are located in Warren, New Jersey, and consist of 6,708 square feet dedicated to corporate, operational, and pre-commercial
activities under a lease that expires February 14, 2026. We also have two research and development facilities located in Philadelphia:
our 3,620 square foot research and development center under a lease that expires June 30, 2025; and a shared facility with laboratory
space dedicated to us that is focused on preclinical and pharmacodynamic activities.
Item
3. Legal Proceedings.
From
time to time, we may become involved in litigation or other legal proceedings arising in the ordinary course of our business. We are
not currently a party to any material pending legal proceedings.
Item
4. Mine Safety Disclosures.
Not
applicable.
79
PART
II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.